Astellas Pharma Inc (OTCPK:ALPMY)
$ 13.73 -0.69 (-4.79%) Market Cap: 24.60 Bil Enterprise Value: 26.29 Bil PE Ratio: 12.80 PB Ratio: 2.21 GF Score: 81/100

Q3 2023 Astellas Pharma Inc Earnings Presentation Transcript

Feb 06, 2023 / NTS GMT
Release Date Price: $14.3 (-0.90%)

Feb 06, 2023 / NTS GMT
Presentation
Feb 06, 2023 / NTS GMT

=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Chairman of the Board
* Minoru Kikuoka
Astellas Pharma Inc. - CFO & Senior Managing Executive Officer
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, Chief Strategy Officer & Representative Director
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot